← Back to headlines
Novo Nordisk and Hims & Hers Deal Benefits Both Stocks
A new deal between pharmaceutical giant Novo Nordisk and health platform Hims & Hers is expected to yield positive outcomes for the stock performance of both companies.
16 Mar, 13:20 — 16 Mar, 13:20
Sources
Showing 1 of 1 sources
Related Stories
Executives at Genelux, Georgia Capital, and Tyler Technologies Sell Company Shares
24m ago
US Considers Targeted Chip Tariffs Amid Trade Discussions With Mexico
27m ago
OPEC+ Expected to Maintain Current Oil Production Quotas
33m ago
New York City Public Schools Ban Artificial Intelligence for Students Through Eighth Grade
36m ago